PIM1 and myeloproliferative neoplasm: AZD1208 treatment of MPN cells frequently led to an increase in PIM1, PIM2, and PIM3 protein (Supplementary Fig. 2A and not shown), suggesting on target inhibition and subsequent stabilization of the protein, as previously reported [54, 59].